Cottonwood Technology Fund — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Circular Genomics develops a proprietary platform using circular RNA biomarkers to enable early detection and understanding of neurological diseases through blood tests.
AI & Machine LearningBiotechDigital HealthMedical DevicesAlbuquerque, US
Alexander Hafez(Executive Officer, Director, Promoter)inNikolaos Mellios(Director, Promoter)
Board seatDavid Blivin· per SEC Form D
Co-investorsMountain Group CapitalTramway Venture Partners
EMPEL develops a PFAS-free water-repellent coating technology that bonds directly to fiber materials for durable, long-lasting performance without wastewater generation.
CleantechNew MaterialsRio Rancho, US
Gary S. Selwyn(Executive Officer, Director)Thomas Lopez(Executive Officer, Director)Martin Flora(Executive Officer, Director)Zachariah Jonasson(Director)Ryan Chen(Director)
Board seatDavid Blivin· per SEC Form D
Co-investorsPangaea Ventures Us Inc.Dangerous VenturesPanamerican VC InvestmentsPangaea VenturesPhoenix Venture PartnersSun Mountain Capital
Infinitum Electric develops high-efficiency electric motors optimized for data center cooling systems, delivering superior energy performance compared to conventional motors.
CleantechEnergyHardwareRound Rock, US
Bernhard Schuler(Executive Officer, Director)Bob Brown(Executive Officer)Rick Tewell(Executive Officer)Bernard Schuler(Executive Officer, Director, Promoter)
BoardBenoit Grobon(Director)Jaime Aguirre(Director)
Board seatDavid Blivin· per SEC Form D
Co-investorsMarunouchi Innovation PartnersChevron Technology Ventures
Q*Bird develops quantum key distribution (QKD) devices and networks for secure data communication using quantum technology, serving commercial and industrial clients including financial institutions, telecommunications companies, and data centers.
CybersecurityEnterprise SoftwareHardwareQuantum ComputingDelft, NL
Ingrid Romijn(CEO)inRemon Berrevoets(CTIO)inJoshua Slater(CTO)in
Co-investorsQDNL Participations
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.